Iron oxide nanoparticles coated with Glucose and conjugated with Safranal (Fe3O4@Glu-Safranal NPs) inducing apoptosis in liver cancer cell line (HepG2)

Springer Science and Business Media LLC - Tập 18 - Trang 1-12 - 2024
Somayeh Mikaeili Ghezeljeh1, Ali Salehzadeh1, Somayeh Ataei-e Jaliseh1
1Department of Biology, Rasht Branch, Islamic Azad University, Rasht, Iran

Tóm tắt

Magnetic nanoparticles can be considered a reliable tool for targeted drug delivery to cancer tissues. Based on this, in this study, the anticancer effect of iron oxide nanoparticles coated with glucose and conjugated with Safranal (Fe3O4@Glu-Safranal NPs) on a liver cancer cell line (HepG2) was investigated. Physicochemical properties of nanoparticles were characterized using FT-IR, XRD, VSM, EDS-mapping, SEM and TEM imaging, zeta potential, and DLS analyses. MTT test was used to investigate the inhibitory effect of nanoparticles on cancer and normal cell lines. Also, the reactive oxygen species (ROS) level, the population of apoptotic cells, and cell cycle analysis were evaluated in control and nanoparticle-treated cells. The synthesized particles were spherical, in a size range of 17–49 nm, without impurities, with a surface charge of − 13 mV and hydrodynamic size of 129 nm, and with magnetic saturation of 22.5 emu/g. The 50% inhibitory concentration (IC50) of Safranal, Fe3O4, Fe3O4@Glu-Safranal and Cisplatin drug on liver cancer cells were 474, 1546, 305 and 135 µg/mL, respectively. While, the IC50 of Fe3O4@Glu-Safranal for normal cell line was 680 µg/mL. Treating liver cancer cells with nanoparticles significantly increased the population of apoptotic cells from 2.5% to 34.7%. Furthermore, the population of the cells arrested at the G2/M phase increased in nanoparticle-treated cells. Due to the biocompatibility of the constituent compounds of these nanoparticles, their magnetic properties, and their inhibitory effects on cancer cells, Fe3O4@Glu-Safranal NPs can be further considered as a promising anticancer compound.

Tài liệu tham khảo

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.

Anwanwan D, Singh SK, Singh S, Saikam V, Singh R. Challenges in liver cancer and possible treatment approaches. Biochimica et Biophysica Acta BBA Revi Cancer. 2020;1873(1): 188314. https://doi.org/10.1016/j.bbcan.2019.188314.

Bahrami B, Hojjat-Farsangi M, Mohammadi H, Anvari E, Ghalamfarsa G, Yousefi M, Jadidi-Niaragh F. Nanoparticles and targeted drug delivery in cancer therapy. Immunol Lett. 2017;190:64–83. https://doi.org/10.1016/j.imlet.2017.07.015.

Mushtaq S, Shahzad K, Saeed T, Ul-Hamid A, Abbasi BH, Ahmad N, Khalid W, Atif M, Ali Z, Abbasi R, Abbasi R. Surface functionalized drug loaded spinel ferrite MFe2O4 (M=Fe Co, Ni, Zn) nanoparticles, their biocompatibility and cytotoxicity in vitro: a comparison. Beilstein Arch. 2021;2021(1):56. https://doi.org/10.3762/bxiv.2021.56.v1.

Kumari P, Ghosh B, Biswas S. Nanocarriers for cancer-targeted drug delivery. J Drug Target. 2016;24(3):179–91. https://doi.org/10.3109/1061186X.2015.1051049.

Pinelli F, Perale G, Rossi F. Coating and functionalization strategies for nanogels and nanoparticles for selective drug delivery. Gels. 2020;6(1):6. https://doi.org/10.3390/gels6010006.

Rezaee R, Hosseinzadeh H. Safranal: from an aromatic natural product to a rewarding pharmacological agent. Iran J Basic Med Sci. 2013;16(1):12.

Malaekeh-Nikouei B, Mousavi SH, Shahsavand S, Mehri S, Nassirli H, Moallem SA. Assessment of cytotoxic properties of safranal and nanoliposomal safranal in various cancer cell lines. Phytother Res. 2013;27(12):1868–73. https://doi.org/10.1002/ptr.4945.

Naghshineh A, Dadras A, Ghalandari B, Riazi GH, Modaresi SMS, Afrasiabi A, Aslani MK. Safranal as a novel anti-tubulin binding agent with potential use in cancer therapy: an in vitro study. Chem Biol Interact. 2015;238:151–60. https://doi.org/10.1016/j.cbi.2015.06.023.

Ashrafian S, Zarrineh M, Jensen P, Nawrocki A, Rezadoost H, Ansari AM, Farahmand L, Ghassempour A, Larsen MR. Quantitative phosphoproteomics and acetylomics of safranal anticancer effects in triple-negative breast cancer cells. J Proteome Res. 2022;21(11):2566–85. https://doi.org/10.1021/acs.jproteome.2c00168.

Habibi A, Sadat Shandiz SA, Salehzadeh A, Moradi-Shoeili Z. Novel pyridinecarboxaldehyde thiosemicarbazone conjugated magnetite nanoparticulates (MNPs) promote apoptosis in human lung cancer A549 cells. J Biol Inorg Chem. 2020;25:13–22. https://doi.org/10.1007/s00775-019-01728-4.

Hosseinkhah M, Ghasemian R, Shokrollahi F, Mojdehi SR, Noveiri MJS, Hedayati M, Rezaei M, Salehzadeh A. Cytotoxic potential of nickel oxide nanoparticles functionalized with glutamic acid and conjugated with thiosemicarbazide (NiO@ Glu/TSC) against human gastric cancer cells. J Clust Sci. 2021. https://doi.org/10.1007/s10876-021-02124-2.

Kumari R, Saini AK, Kumar A, Saini RV. Apoptosis induction in lung and prostate cancer cells through silver nanoparticles synthesized from Pinus roxburghii bioactive fraction. J Biol Inorg Chem. 2020;25(1):23–37. https://doi.org/10.1007/s00775-019-01729-3.

Shandiz SAS, Montazeri A, Abdolhosseini M, Shahrestani SH, Hedayati M, Moradi-Shoeili Z, Salehzadeh A. Functionalization of Ag nanoparticles by glutamic acid and conjugation of Ag@ Glu by thiosemicarbazide enhances the apoptosis of human breast cancer MCF-7 cells. J Cluster Sci. 2018;29(6):1107–14. https://doi.org/10.1007/s10876-018-1424-0.

Emami N, Farhadian M, Solaimany Nazar AR, Tangestaninejad S. Adsorption of cefixime and lamotrigine on HKUST-1/ZIF-8 nanocomposite: isotherms, kinetics models and mechanism. Int J Environ Sci Technol. 2023;20(2):1645–72. https://doi.org/10.1007/s13762-022-04679-7.

Abbaszadegan S, Al-Marzouqi AH, Salem AA, Amin A. Physicochemical characterizations of safranal-β-cyclodextrin inclusion complexes prepared by supercritical carbon dioxide and conventional methods. J Incl Phenom Macrocycl Chem. 2015;83:215–26. https://doi.org/10.1007/s10847-015-0555-2.

Wei W, Yang S, Zhou H, Lieberwirth I, Feng X, Müllen K. 3D graphene foams cross-linked with pre-encapsulated Fe3O4 nanospheres for enhanced lithium storage. Adv Mater. 2013;25(21):2909–14. https://doi.org/10.1002/adma.201300445.

Han F, Ma L, Sun Q, Lei C, Lu A. Rationally designed carbon-coated Fe 3 O 4 coaxial nanotubes with hierarchical porosity as high-rate anodes for lithium ion batteries. Nano Res. 2014;7:1706–17. https://doi.org/10.1007/s12274-014-0531-y.

Tiwari S, Prakash R, Choudhary RJ, Phase DM. Oriented growth of Fe3O4 thin film on crystalline and amorphous substrates by pulsed laser deposition. J Phys D Appl Phys. 2007;40(16):4943. https://doi.org/10.1088/0022-3727/40/16/028.

Fujii T, De Groot FMF, Sawatzky GA, Voogt FC, Hibma T, Okada K. In situ XPS analysis of various iron oxide films grown by NO2-assisted molecular-beam epitaxy. Phys Rev B. 1999;59(4):3195. https://doi.org/10.1103/PhysRevB.59.3195.

Burger AM, Fiebig HH. Preclinical screening for new anticancer agents. Handbook of anticancer pharmacokinetics and pharmacodynamics. 2014;23–38. https://doi.org/10.1007/978-1-4614-9135-4_2

Rahdar A, Amini N, Askari F, Susan MABH. Dynamic light scattering: a useful technique to characterize nanoparticles. J Nanoanal. 2019;6(2):80–9. https://doi.org/10.22034/JNA.2019.667079.

Vangijzegem T, Stanicki D, Laurent S. Magnetic iron oxide nanoparticles for drug delivery: applications and characteristics. Expert Opin Drug Deliv. 2019;16(1):69–78. https://doi.org/10.1016/j.apsusc.2013.02.072.

Lee KH, Liapi E, Vossen JA, Buijs M, Ventura VP, Georgiades C, Hong K, Kamel I, Torbenson MS, Geschwind JFH. Distribution of iron oxide–containing Embosphere particles after transcatheter arterial embolization in an animal model of liver cancer: evaluation with MR imaging and implication for therapy. J Vasc Interv Radiol. 2008;19(10):1490–6. https://doi.org/10.1016/j.jvir.2008.06.008.

Tietze R, Lyer S, Dürr S, Struffert T, Engelhorn T, Schwarz M, Eckert E, Göen T, Vasylyev S, Peukert W, Wiekhorst F, Trahms T, Dörfler A, Alexiou C. Efficient drug-delivery using magnetic nanoparticles—biodistribution and therapeutic effects in tumour bearing rabbits. Nanomed Nanotechnol Biol Med. 2013;9(7):961–71. https://doi.org/10.1016/j.nano.2013.05.001.

Al-Hrout AA, Chaiboonchoe A, Khraiwesh B, Murali C, Baig B, El-Awady R, Tarazi H, Alzahmi A, Nelson DR, Greish YE, Ramadan W, Salehi-Ashtiani K, Amin A. Safranal induces DNA double-strand breakage and ER-stress-mediated cell death in hepatocellular carcinoma cells. Sci Rep. 2018;8(1):16951. https://doi.org/10.1038/s41598-018-34855-0.

Khan MI, Mohammad A, Patil G, Naqvi SAH, Chauhan LKS, Ahmad I. Induction of ROS, mitochondrial damage and autophagy in lung epithelial cancer cells by iron oxide nanoparticles. Biomaterials. 2012;33(5):1477–88. https://doi.org/10.1016/j.biomaterials.2011.10.080.

Kettler K, Veltman K, Van de Meent D, Van Wezel A, Hendriks AJ. Cellular uptake of nanoparticles as determined by particle properties, experimental conditions, and cell type. Environ Toxicol Chem. 2014;33(3):481–92. https://doi.org/10.1002/etc.2470.

Zhang Y, Zhao Y, Guo J, Cui H, Liu S. Anticancer activity of safranal against colon carcinoma is due to induction of apoptosis and G2/M cell cycle arrest mediated by suppression of mTOR/PI3K/Akt pathway. JBU ON. 2018;23(3):574–8.

Thông tin
Thông tin xuất bản

Springer Science and Business Media LLC

Tập 18

1-12

Thông tin tác giả